In this paper we present an LFA designed for the detection of the nucleocapsid protein of SARS-CoV-2. Significantly, it meets the stated analytical sensitivity requirements proposed by WHO. We utilize only commercially available reagents and conventional protocols, to allow the straightforward duplication and modification of this LFA. The LOD of this assay meets the requirements stated by the WHO for use as a POC test. Further work includes validation of the assay in a clinical setting and its performance using different specimen types.